Current location - Recipe Complete Network - Complete breakfast recipes - Can dapoxetine hydrochloride tablet treat glans penis with high sensitivity?
Can dapoxetine hydrochloride tablet treat glans penis with high sensitivity?
Bipolar hydrochloride tablets mainly inhibit sympathetic nerve and reduce sensitivity, but this is a western medicine, which treats the symptoms rather than the root cause.

1. dapoxetine hydrochloride tablet is suitable for the treatment of male premature ejaculation (PE) patients aged from 18 to 64, and meets all the following conditions: the penis ejaculates continuously or repeatedly due to minimal sexual stimulation before, during or shortly after insertion into the vagina, and before sexual satisfaction; And the obvious personal distress or interpersonal barriers caused by premature ejaculation (PE); Poor ejaculation control ability.

Second, this product is suitable for the treatment of male premature ejaculation (PE) patients aged 18 to 64, and meets all the following conditions: the penis ejaculates continuously or repeatedly due to minimal sexual stimulation before, during or shortly after insertion into the vagina; And the obvious personal distress or interpersonal barriers caused by premature ejaculation (PE); Poor ejaculation control ability.

Third, take orally. The pills should be swallowed whole. Patients are advised to take medicine with at least one full glass of water. Patients should try to avoid injuries caused by aura symptoms such as syncope or dizziness.

Four, all patients recommend the first dose of 30mg, need to take about 0 ~ 3 hours before sex 1. If the effect is not satisfactory after taking 30mg, and the side effects are still within the acceptable range, the dose can be increased to 60mg of the maximum recommended dose. The recommended maximum dose frequency is once every 24 hours.

5. If the doctor chooses this product to treat premature ejaculation, he should evaluate the risk and benefit reported by the patient within the first 4 weeks after using this drug, or evaluate the risk-benefit balance of the patient after using the therapeutic dose for 6 times, and decide whether to continue using this product for treatment.

6. The safety of this product was evaluated in 60,865,438+0 premature ejaculation patients who participated in five double-blind, placebo-controlled clinical trials. Among these subjects, 4,222 patients received this product, of which 65,438+0,665,438+05 patients received 30mg of this product as needed, and 2,607 patients received 60 mg of this product or were given drugs as needed.